Medical Journals

Aminoglycoside-induced Reduction in Nucleotide Mobility at the Ribosomal Rna A-site As a Potentially Key Determinant of Antibacterial Activity.

Authors:
  • Kaul Malvika
  • Barbieri Christopher M
  • Pilch Daniel S

From: Department of Pharmacology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Piscataway, 08854-5635, USA.

Journal of the American Chemical Society

  • Publish Date: Feb 2006
  • ISSN: 0002-7863
  • Volume: 128
  • Issue: 4
  • Pages: 1261-71
  • Medium: Print
  • Language: English
  • Citation (JAMA): Kaul Malvika, Barbieri Christopher M, Pilch Daniel S, et al. Aminoglycoside-induced Reduction in Nucleotide Mobility at the Ribosomal Rna A-site As a Potentially Key Determinant of Antibacterial Activity.. J. Am. Chem. Soc. Feb 2006;128:1261-71

Abstract

Steady-state and time-resolved fluorescence techniques have been used to characterize the energetics and dynamics associated with the interaction of an E. coli 16 S rRNA A-site model oligonucleotide and four aminoglycoside antibiotics that exhibit a broad range of antibacterial activity. The results of these characterizations suggest that aminoglycoside-induced reduction in the mobility of an adenine residue at position 1492 of the rRNA A-site is a more important determinant of antibacterial activity than drug affinity for the A-site. This observation is consistent with a recently proposed model for the mechanism of protein synthesis inhibition by aminoglycosides that invokes a drug-induced alteration in the conformational equilibrium of the rRNA A-site (centered around the conserved adenine residues at positions 1492 and 1493), which, in turn, promotes an enhanced interaction between the rRNA and the minihelix formed by the tRNA anticodon and the mRNA codon, even when the anticodon is noncognate. Regarded as a whole, the results reported here indicate that the rational design of antibiotics that target the 16 S rRNA A-site requires consideration of not only the structure and energetics of the drug-RNA complex but also the dynamics associated with that complex.

Mesh Headings (Keywords): 2-Aminopurine, Adenine, Aminoglycosides, Anti-Bacterial Agents, Binding Sites, Carbohydrate Sequence, Escherichia coli, Molecular Sequence Data, Paromomycin, RNA, Ribosomal, 16S, Ribostamycin, Spectrometry, Fluorescence


Check for Full Text / PubMed Unique Identifier (PMID): 16433544


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.